آخر تحديث :
19/11/2024
Infostab
قائمة المركبات
ملخص القوائم
ابحث عن التوافق
جدول توافق موقع ص
مراجع
فرق البحث
valistab
الملصق
الروابط
الرعاة
الكتاب
دليل المستخدم
النشرة الإخبارية
فرق البحث - Nippon Medical School Hospital, Department of Pharmacy
Nippon Medical School Hospital, Department of Pharmacy
Tokyo
senoo@nms.ac.jp
مراجع
(4)
1
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.
Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H. (kondomasayoshi@nms.ac.jp)
Journal of Nippon Medical school -
2023
-
2
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H (kondomasayoshi@nms.ac.jp)
Am J Health-Syst Pharm -
2022
- https://doi.org/10.1093/a
3
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H. (kondomasayoshi@nms.ac.jp)
Journal of Nippon Medical school -
2021
-
4
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method.
Senoo M, Tajika K, Shimizu H, Hamada M, Dobashi Y, Dan K, Katayama S. (senoo@nms.ac.jp)
Yakugaku Zasshi -
2009
- 129, 6: 767-771.
جزيئات درس
(16)
Busulfan
Dexmedetomidine
Fentanyl citrate
Furosemide
Heparin sodium
Hydromorphone hydrochloride
Midazolam hydrochloride
Morphine hydrochloride
Nafamostat
Octreotide acetate
Oxycodone hydrochloride
Remdesivir
Remifentanil hydrochloride
Remimazolam
Rocuronium bromide
Vecuronium bromide
Mentions Légales